Data / Drug companies / Advance Pharmaceutical Inc.
Advance Pharmaceutical Inc.: 24 products in the FDA NDC directory, labeler code 17714
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Advance Pharmaceutical Inc. (labeler code 17714) lists 24 products in the FDA National Drug Code Directory, covering 12 finished drugs by generic name. By type: 24 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on November 11, 2021.
The request: Watch Advance Pharmaceutical Inc. (FDA labeler code 17714): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 17714
- Products in commercial distribution
- 24
- Packages
- 38
- Finished drugs by generic name
- 12
- Prescription products
- 0
- Over the counter products
- 24
- Flagged as original packager
- 24 of 24 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- April 15, 1988
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 24 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 24 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Diphenhydramine hydrochloride | 4 | 127 |
| Aspirin | 4 | 134 |
| Calcium carbonate | 3 | 101 |
| Simethicone | 3 | 86 |
| Acetaminophen | 3 | 214 |
| Bismuth subsalicylate | 1 | 80 |
| Chlorpheniramine maleate | 1 | 31 |
| Meclizine hcl 12.5 mg | 1 | 6 |
| Guaifenesin 400 mg | 1 | 8 |
| Guaifenesin and dextromethorphan hbr | 1 | 26 |
| Meclizine hcl 25mg chewable tablets | 1 | 3 |
| Acetaminophen pm | 1 | 2 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 14 | 58.3% |
| Tablet, chewable | 7 | 29.2% |
| Capsule | 2 | 8.3% |
| Gel | 1 | 4.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Simethicone Certified Plus | 17714-076 | Gel | Over the counter monograph drugs | November 11, 2021 |
| Mucus Relief Cough and Congestion DM | 17714-150 | Tablet | Over the counter monograph drugs | August 1, 2017 |
| Mucus Relief | 17714-152 | Tablet | Over the counter monograph drugs | November 1, 2016 |
| Meclizine HCL 12.5 mg | 17714-117 | Tablet | Over the counter monograph drugs | July 1, 2013 |
| Meclizine HCL | 17714-115 | Tablet, chewable | Over the counter monograph drugs | July 1, 2013 |
| Simethicone | 17714-040 | Tablet, chewable | Over the counter monograph drugs | November 1, 2012 |
| Diphenhydramine Hydrochloride | 17714-023 | Tablet | Over the counter monograph drugs | September 1, 2012 |
| Antacid | 17714-041 | Tablet, chewable | Over the counter monograph drugs | November 30, 2007 |
| Diphenhydramine Hydrochloride | 17714-135 | Tablet | Over the counter monograph drugs | September 26, 2006 |
| Acetaminophen pm | 17714-133 | Tablet | Over the counter monograph drugs | January 9, 2002 |
| Pepto Relief | 17714-045 | Tablet, chewable | Over the counter monograph drugs | January 9, 2002 |
| Anti Allergy | 17714-016 | Tablet | Over the counter monograph drugs | January 9, 2002 |
| Aspirin | 17714-010 | Tablet | Over the counter monograph drugs | January 9, 2002 |
| Gas Relief | 17714-019 | Tablet, chewable | Over the counter monograph drugs | November 4, 1999 |
| Aspirin | 17714-121 | Tablet | Over the counter monograph drugs | June 12, 1999 |
| Antacid | 17714-043 | Tablet, chewable | Over the counter monograph drugs | January 26, 1996 |
| Aspirin | 17714-011 | Tablet | Over the counter monograph drugs | May 8, 1990 |
| Antacid | 17714-025 | Tablet | Over the counter monograph drugs | April 6, 1990 |
| Apap | 17714-014 | Tablet | Over the counter monograph drugs | January 14, 1990 |
| Diphenhydramine Hydrochloride | 17714-021 | Capsule | Over the counter monograph drugs | October 5, 1989 |
| Diphenhydramine Hydrochloride | 17714-020 | Capsule | Over the counter monograph drugs | September 12, 1989 |
| Apap | 17714-013 | Tablet | Over the counter monograph drugs | February 5, 1989 |
| Acetaminophen | 17714-012 | Tablet | Over the counter monograph drugs | February 5, 1989 |
| Aspirin | 17714-009 | Tablet, chewable | Over the counter monograph drugs | April 15, 1988 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.